Cross-fund · 1 holders
AVDL
AVADEL PHARMACEUTICALS PLC
CUSIP G29687103
1
Tracked holders
$126.4M
Aggregate value
5,864,781
Shares
5
Active funds
Funds holding AVDL
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $126.4M | — | +258,499 | +4.6% |
| BlackRock | Institutional | Q1 2026 | — | — | −7,041,102 | EXITED |
| Citadel | Multi-Strategy | Q1 2026 | — | — | −935,432 | EXITED |
| Millennium | Multi-Strategy | Q1 2026 | — | — | −84,085 | EXITED |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | −299,725 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.